このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Flora Growth 過去の業績

過去基準チェック /06

Flora Growthの収益は年間平均-42.9%の割合で減少していますが、 Personal Products業界の収益は年間増加しています。収益は年間14.8% 85.1%割合で増加しています。

主要情報

-33.3%

収益成長率

-0.7%

EPS成長率

Personal Products 業界の成長	20.9%
収益成長率	72.8%
株主資本利益率	-151.4%
ネット・マージン	-19.5%
前回の決算情報	30 Jun 2024

Recent updates

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Sep 18

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Aug 16

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

May 22

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Apr 04

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

Feb 17

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Dec 22

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Apr 17

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Dec 08

Flora Growth gains on deal to acquire No Cap Hemp assets

Sep 07

Elshad Garayev is the new finance chief of Flora Growth

Jul 11

収支内訳

Flora Growth の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NasdaqCM:FLGC 収益、費用、利益 ( )USD Millions
日付	収益	収益	G+A経費
30 Jun 24	69	-13	20
31 Mar 24	75	-48	22
31 Dec 23	76	-47	24
30 Sep 23	69	-50	24
30 Jun 23	61	-57	28
31 Mar 23	48	-42	27
31 Dec 22	33	-46	30
30 Sep 22	28	-48	33
30 Jun 22	20	-45	29
31 Mar 22	13	-26	26
31 Dec 21	9	-21	20
30 Sep 21	4	-15	15
30 Jun 21	2	-17	16
31 Mar 21	1	-15	14
31 Dec 20	0	-14	12
30 Jun 20	0	-4	4

質の高い収益: FLGCは現在利益が出ていません。

利益率の向上: FLGCは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: FLGCは利益が出ておらず、過去 5 年間で損失は年間42.9%の割合で増加しています。

成長の加速: FLGCの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: FLGCは利益が出ていないため、過去 1 年間の収益成長をPersonal Products業界 ( 6.9% ) と比較することは困難です。

株主資本利益率

高いROE: FLGCは現在利益が出ていないため、自己資本利益率 ( -1493.21% ) はマイナスです。

Flora Growth 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2023 earnings: Revenues miss analyst expectations

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Recent updates

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Flora Growth Corp. Announces Board Changes

Flora Growth Announces Update on Compliance with the Audit Committee Composition Requirements of Nasdaq Listing Rule 5605(c)(2)(A)

Consensus revenue estimates fall by 12%

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp. (NasdaqCM:FLGC) acquired Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV:LFST) for CAD 0.87 million.

Flora Growth Corp., Annual General Meeting, Aug 14, 2024

High number of new and inexperienced directors

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

Consensus EPS estimates upgraded to US$0.41 loss, revenue downgraded

Forecast to breakeven in 2025

First quarter 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Shareholder dilution

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Flora Growth Corp. has completed a Follow-on Equity Offering in the amount of $3.23 million.

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

New major risk - Market cap size

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Flora Growth Corp. Receives Non-Compliance Notice From NASDAQ

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

Flora Growth Corp. Announces the Resignation of Juan Carlos Roa Gomez as Director

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. (NasdaqCM : FLGC) entered into a Sale and Purchase Agreement to acquire Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST) for $1.9 million.

Second quarter 2023 earnings: Revenues miss analyst expectations

Flora Growth Corp. Announces Resignation of Matthew Cohen as General Counsel

Flora Growth Corp. Appoints Dany Vaiman as Chief Financial Officer

Flora Growth Regains Compliance with Nasdaq Minimum Bid Requirement

Consensus EPS estimates upgraded to US$0.03 loss

Flora Growth Corp. Announces Board Appointments

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates upgraded to US$0.21 loss

Price target decreased by 24% to US$1.33

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Price target increased by 18% to US$2.92

Flora Growth Corp Provides Revenue Guidance for the Year 2023

Flora Growth Corp. Announces Executive Changes

Price target decreased to US$2.12

Forecast to breakeven in 2024

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Independent Director notifies of intention to sell stock

Third quarter 2022 earnings: EPS misses analyst expectations

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Price target decreased to US$2.67

High number of new and inexperienced directors

Flora Growth Corp. (NasdaqCM:FLGC) entered into a definitive agreement to acquire Franchise Global Health Inc. (TSXV:FGH) for CAD 32.2 million.

No longer forecast to breakeven

Flora Growth gains on deal to acquire No Cap Hemp assets

First half 2022 earnings released: US$0.42 loss per share (vs US$0.13 loss in 1H 2021)

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Flora Growth Corp. to Report First Half, 2022 Results on Aug 15, 2022

High number of new and inexperienced directors

Flora Growth Appoints Elshad Garayev as Chief Financial Officer

Elshad Garayev is the new finance chief of Flora Growth

Flora Growth Corp. Announces Board Appointments

Flora Growth Corp. (NasdaqCM:FLGC) announces an Equity Buyback for $5 million worth of its shares.

Flora Growth Corp., Annual General Meeting, Jul 05, 2022

Flora Growth Corp. (NasdaqCM:FLGC) and Annabelle Manalo-Morgan agreed to acquire Masaya Medical, Inc.

Flora Growth Corp. Reiterates Earnings Guidance for the Full Year 2022

Flora Growth Corp. to Report Fiscal Year 2021 Results on May 10, 2022

Flora Growth Corp. Announces Launch of New Skincare Line Under Its Brand, MIND Naturals

High number of new and inexperienced directors

Flora Growth Corp. Appoints Jessie Casner as Chief Marketing Officer to Drive Growth of Brand Portfolio

Flora Growth Registers First-Ever Cannabinoid Food and Beverage Products with Colombian-FDA

過去基準チェック /06